gm

I have no pm possibility anymore. I asked a friend to send you my email address via pm, but he obviously did not do it. I don´t want to put it in here so that anybody can read it. I will try to send it to you on friday during happy hour. here is my friends ihub profil.

https://investorshub.advfn.com/boards/profilea.aspx?user=60294

send him a message pls that I sent him an elamil 1 week agaio to send you my email address. If you tell him my first name he will have a look. thanks so much.

the otherstock did already move. I did not see your pm before today. what a pity.

cheers,

I just saw your post as I am almost not online anymore here- That is so sad, but he had to fight a longtime against this terrible illness and now he does not have to suffer anymore.. God bless him and thanks for posting to let others know. E

thanks for the pm :) I have no premium anymore. cannot answer. give me your email pls. :) e

gm, do you have the earningscall transsript complete? on STW they have a link to the Seeking Alpha transcript, which is not complete and one has to pay SA to read it in full. Would be great if you could post the complete text here from the call yesterday. great company with a great future imo :) thanks

gm free

I have no pm possibility anymore. and I sold FECOF a longtime ago on one ofthe runs. Pls. send your pm to irishintelligence, I guess he is still involved. I am not. I dod not even know if this list is still actual as this was in 2018.

good luck, go

it would be nice to hear something again from the company. I sent several emails and never got an answer. I asked as a "client" , not as a shareholder.. very strange and boring

thanks for the PM SP. I have no premium anymore, so cannot answer. All good and nice here

so one APE share should be around 9.98 when market opens? do I get that right?

and yet a new scam in the making with old staff... lol

https://opencorporates.com/companies/us_fl/F22000002945

what this water can...

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169306083

first step is done.. thanks for the info. I missed that yesterday. hopefully they are getting this going with this terrible market environment.. keeping my fingers crossed :)

great post. thanks

after doing more research on Aquaporin, I see a lot of use in Cosmetic products and medical products. What cannot find is the answer to that question:

will this water be produced for industrial use (cosmentis, pharmacy, etc) or will this water be sold as drinking water.? anyone??

the water is not only normal water, it´s special. I oversaw that first. But it seems to be something interesting so

Question remains, how much it cost and if people are willing to spend it and if they belief it will work

The Golden Ally Lifetech (“GALTG”) AQP Active Water project is a derivative of an academic inspiration from the 2003 Nobel Laureates in Chemistry, Peter Agre, for the discovery and pioneering research of water channels, also called aquaporins (“AQP”), in cell membranes.

The AQP active water technology roots from Japan, where the founder Prof. Kitagawa uncovered that water treated by an exclusive proprietary material offered enhanced biological effects. He proposed that the structure of water cluster altered by this proprietary water technology fundamentally distinguishes the AQP water with other functional waters.

His exclusive partnership with a U.S.-based engineering team aims to mass-produce proprietary AQP water, firstly offering the distinctive water products in the U.S. GALT’s mission is to advance human health through our proprietary water technology. Cells are the basic structural and functional units of life, consisting of a cytoplasm enclosed with a cell membrane. Cell membrane provides a protective barrier around the cell while regulates which materials or molecule can pass in or not. Like ionic channels, such as calcium ion (Ca2+) channel, potassium ion (K+) channel, sodium ion (Na+) channel, and proton (H+) channel, that regulate the transport of ions across the cell membrane, the transport of water across the cell membrane is mediated through water channels, also called aquaporins, and driven by the osmosis pressure across the cell membrane


Aquaporin

From Wikipedia, the free encyclopedia
Jump to navigationJump to search
Aquaporin
Aquaporin-Sideview.png
Crystallographic structure of aquaporin 1 (AQP1) PDB 1j4n
Identifiers
Symbol Aquaporin
Pfam PF00230
InterPro IPR000425
PROSITE PDOC00193
SCOP2 1fx8 / SCOPe / SUPFAM
TCDB 1.A.8
OPM superfamily 7
OPM protein 2zz9
Available protein structures:
Aquaporins, also called water channels, are channel proteins from a larger family of major intrinsic proteins that form pores in the membrane of biological cells, mainly facilitating transport of water between cells.[1] The cell membranes of a variety of different bacteria, fungi, animal and plant cells contain aquaporins through which water can flow more rapidly into and out of the cell than by diffusing through the phospholipid bilayer.[2] Aquaporins have six membrane-spanning alpha helical domains with both carboxylic and amino terminals on the cytoplasmic side. Two hydrophobic loops contain conserved asparagine-proline-alanine ("NPA motif") which form a barrel surrounding a central pore-like region that contains additional protein density.[3] Because aquaporins are usually always open and are prevalent in just about every cell type, this leads to a misconception that water readily passes through the cell membrane down its concentration gradient. Water can pass through the cell membrane through simple diffusion because it is a small molecule, and through osmosis, in cases where the concentration of water outside of the cell is greater than that of the inside. However, because water is a polar molecule this process of simple diffusion is relatively slow, and in tissues with high water permeability the majority of water passes through aquaporin.[4][5]

The 2003 Nobel Prize in Chemistry was awarded jointly to Peter Agre for the discovery of aquaporins[6] and Roderick MacKinnon for his work on the structure and mechanism of potassium channels.[7]

Genetic defects involving aquaporin genes have been associated with several human diseases including nephrogenic diabetes insipidus and neuromyelitis optica.

https://en.wikipedia.org/wiki/Aquaporin

yes, disappointing. and they start at 0 with the business. That will take a few years until they have revenue imo.

Our Business

As a result of the Transactions, Signet’s operations will be conducted through its subsidiary Golden Ally. Golden Ally is focused on its Aquaporin (“AQP”) Active Water project, which is a derivative of an academic inspiration from the 2003 Nobel Laureates in Chemistry, Dr. Peter Agre and Dr. Roderick MacKinnon jointly, “for discoveries concerning channels in cell membranes”. Golden Ally has been working closely with experienced field experts and top scientific research institutions to apply the famous Nobel Prize theory of aquaporins into its commercialized products, i.e., the AQP Active Water.

AQP Active Water is the product of a unique water filtration technology derived from raw materials with exclusive access by Golden Ally. The advanced technology can enhance water filtration for better body cell absorption to improve health. All AQP Active Water products are expected to be produced through OEM arrangements and their distribution logistics will also be supported by the OEM partners.

AQP Active Water is an epoch-making product. Consumption for a prolonged period is foreseen to possibly extend human body cells’ lifespan. Golden Ally has been running laboratory tests on its products at the David Geffen School of Medicine at University of California, Los Angeles.

High-income households are Golden Ally’s targeted consumers due to a strong correlation between income level and health spending. The global consumer pool for AQP Active Water is estimated at 17.61 million households. These households represent the portion that has an annual household income of over $150,000 USD, a level that can potentially support annual household spending on healthcare products.


(well, good luck with that.. but in the actual environment people have probably other worries than drinking healthy water instead of normal water.. I am not very optimistic that this business model will bring us the big money.. I hope I am wrong in that estimation) thoughts??

when I get that right, we are involved only in the water part of golden Ally. nothing with the E-cars so...

Results of Operations
Overview

Golden Ally is a developmental stage company that is currently implementing its business plan, which is to be a high-tech start-up focused on a unique product offering. Our activities to date have focused on the development and exploration of water filtration technology and consumer products with AQP Active Water. We have been working with field experts and research institutions to apply and explore the ability to enhance water filtration for improved body cell absorption in commercialized water products.

why I am not surprised - lol

This company is a complete failture

Statera Biopharma Receives Notification Letter from Nasdaq Regarding Form 10-Q Filing

FORT COLLINS, Colo., May 23, 2022 (GLOBE NEWSWIRE) -- Statera Biopharma (Nasdaq: STAB) (the “Company”), a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today announced the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on May 18, 2022 indicating that, because the Company was delinquent in filing its quarterly report on Form 10-Q on May 15, 2022 for the first quarter ended March 31, 2022, the Company had not complied with Nasdaq Listing Rule 5250(c)(1) for continued listing.

Statera is searching to identify a new independent registered public accounting firm. The Company will disclose the engagement of the new firm in accordance with SEC rules and regulations once the process has been completed. The Company recently restructured to reduce cash burn and conserve resources. The Company is also working to complete the previously announced transactions with Coeptis Therapeutics, Inc. and Immune Therapeutics, Inc. to out-license certain assets. In addition, the Company has the potential to reinvirogate its pipeline with certain assets from Lay Sciences, Inc. as previously announced.

On April 19, 2022, the Company received notification from Nasdaq that it had failed to comply with Nasdaq Listing Rule 5250(c)(1) because it was delinquent in filing its Annual Report on Form 10-K for the period ending December 31, 2021. In a subsequent letter dated May 18, 2022 the Company received further notification from Nasdaq that it had failed to comply with Nasdaq Listing Rule 5250(c)(1) because it was delinquent in filing its Quarterly Report on Form 10-Q for the three-month period ending March 31, 2022.

In accordance with Nasdaq’s letters dated April 19, 2022 and May 18, 2022, the Company has until June 20, 2022 to submit a plan to regain compliance with respect to the delinquencies described in this announcement. Any Nasdaq exception to allow the Company to regain compliance, if granted, will be limited to a maximum of 180 calendar days from the due date of the initial delinquent filing of the Company’s 2021 Form 10-K, or October 17, 2022. The Company intends to submit a timely plan.

I agree. Would be nice to hear a world from the company where we stand now and how it will take to see any change..

not sure if that was posted before. Interesting

thank you very much for your thoughts. they are so much appreciated. wish you a nice weekend!

any thoughts on the numbers?? thanks

Outlook Therapeutics GAAP EPS of -$0.09 misses by $0.03

May 13, 2022 8:06 AM ETOutlook Therapeutics, Inc. (OTLK)By: Deepa Sarvaiya, SA News Editor

Outlook Therapeutics press release (NASDAQ:OTLK): Q2 GAAP EPS of -$0.09 misses by $0.03.

At March 31, 2022, Outlook Therapeutics had cash and cash equivalents of $58.4 million, compared to $70.2 million at December 31, 2021.

why is the LICY board on ihub transferred to Peridot Acquisition? What is the connection ofthe 2 companies?? thanks

any thoughts on that, thanks

https://ih.advfn.com/stock-market/NYSE/li-cycle-LICY/stock-news/88032587/licy-shareholder-alert-jakubowitz-law-reminds-li

why was the net loss higher this quearter? any idea?

Net loss for the first quarter ended April 2, 2022 was ($5.9) million , or ( $0.03 ) per share, compared to a net loss in the prior year period of ($4.0) million , or a loss per share of ( $0.02

Net sales for the first quarter ended April 2, 2022 were $50.2 million , compared to net sales of $14.9 million for the first quarter ended April 3, 2021 and $36.3 million in the prior quarter.

amazing!!!!

imi they had to put that up in the filing to satisfy the SEC rules. There will be no R/S. but they have to stay above 1.00 for a certain time and then they have still 180 days to solve the problem. it was just random requirement for the filing

at the end ofthe day. STAB was up 67,5% and IMUN 53.6%

I really hope we are not going to market with the symbol chance while this horrible market conditions are still ongoing. They should wait until we get a turn around to start positive with the new company.

I hope this turn around is close. it´s almost amazing how low good stocks have been pushed for 5 months now..

how can you put a stop loss on book shares which are still held by the transfer agent?

and everyone who bought the private placements in Cytocom 3 years ago. Everybody lost it all, me included

EDSA mentioned and the company of course does not tell anything to investors.. Imo this is important and the stock will fly when the market turns or the company will put out great news

https://magazine.utoronto.ca/research-ideas/health/preventing-the-next-pandemic-emerging-and-pandemic-infections-consortium-epic/

hehehe, there are a lot of people thinking the same - lol. Increasing my supplements to have greater chances - heheh

I hope so. Nice news today. time to add imo

looking good here. Still holding book shares, which I did already write off last year. but it seems they are worth something in 1-3 years... good luck to all :)

yes, thanks. All perfect here. I have just retired a bit from the daily watching. Market is very bad for months now. so just watching what is cheap to buy for the turn around. thanks for asking :) enjoy your weekend

I had to buy more shares today on that dip. I wish everyone a wonderful easter holiday weekend :)

we can all sign this petition to help

https://www.urvin.finance/advocacy/we-the-investors-pfof-sign-on

ok, I am now fully in MULN. I am not an expert in EV cars, but I liked the outlook and plans. Now I saw this post on STW and I would like to hear your guys opinion on the content. It´s actually very negative for MULN, but it can be a shrot or some competitor as well.

thanks for your thoughts!

https://investorplace.com/2022/04/why-investors-should-stay-away-from-muln-stock/

true, but shortterm I believe people are afraid to get rejected again and the price may drop back to 0.80. it´s all possible

fracaso total Mr. Handley!!!